Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.
The development of a nosocomial pneumonia is facilitated by alterations in host innate pulmonary antibacterial defenses following surgical trauma, which can result in decreased pulmonary bacterial clearance and increased morbidity and mortality. In a murine model of postoperative nosocomial infection, surgical stress (laparotomy) decreased Escherichia coli clearance from the lungs of animals that underwent surgery. Consistent with previous studies, (i) pulmonary levels of tumor necrosis factor alpha at 6 h and of interleukin-1beta (IL-1beta), IL-6, and gamma interferon (IFN-gamma) at 24 h post-bacterial infection (PBI) were decreased in animals that underwent laparotomy 24 h prior to E. coli infection (LAP/E. coli) compared to animals that received E. coli only; (ii) KC and macrophage inhibitory protein 2 were elevated at 6 h PBI in LAP/E. coli animals compared to E. coli-only animals; however, at 24 h PBI, levels were higher in the E. coli-only group; (iii) at 24 h PBI, monocyte chemoattractant protein 1 was lower in the LAP/E. coli group compared to the E. coli-only group; (iv) IL-10 levels were unaffected at all time points evaluated; and (v) the total number of neutrophils present in the lungs of LAP/E. coli animals at 6 h PBI was decreased in comparison to that in E. coli-only animals, resulting in decreased bacterial clearance and increased mortality in LAP/E. coli animals by 24 h PBI. Similar changes in cytokine profiles, pulmonary bacterial clearance, and mortality were consistent with reported findings in patients following surgical trauma. This model, therefore, provides a clinically relevant system in which the molecular and cellular mechanisms that lead to the development of nosocomial pneumonia can be further explored.
Manderscheid
Patricia A
PA
Department of Anesthesiology, University at Buffalo, Buffalo, New York 14214, USA. pam28@buffalo.edu
Bodkin
Ryan P
RP
Davidson
Bruce A
BA
Jensen
Erik
E
Russo
Thomas A
TA
Knight
Paul R
PR
D000818:Animals; D003428:Cross Infection / Q000209:etiology* / Q000276:immunology; D016207:Cytokines / Q000276:immunology*; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology; D007813:Laparotomy / Q000009:adverse effects; D008168:Lung / Q000276:immunology / Q000382:microbiology; D051379:Mice; D011014:Pneumonia / Q000209:etiology* / Q000276:immunology*; D011183:Postoperative Complications / Q000276:immunology* / Q000382:microbiology
D016207:Cytokines